Manning & Napier Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$22.6M Sell
307,930
-26,410
-8% -$2.03M 0.26% 82
2023
Q4
$27.1M Sell
334,340
-57,475
-15% -$4.47M 0.32% 74
2023
Q3
$29.4M Sell
391,815
-5,359
-1% -$412K 0.36% 73
2023
Q2
$30.6M Buy
397,174
+23,077
+6% +$1.84M 0.35% 75
2023
Q1
$31M Sell
374,097
-692
-0.2% -$57.3K 0.36% 72
2022
Q4
$32.2M Sell
374,789
-4,154
-1% -$329K 0.4% 66
2022
Q3
$23.4M Sell
378,943
-5,066
-1% -$319K 0.31% 83
2022
Q2
$23.7M Sell
384,009
-41,336
-10% -$2.56M 0.27% 83
2022
Q1
$25.3M Sell
425,345
-28,726
-6% -$1.84M 0.24% 94
2021
Q4
$33M Sell
454,071
-23,939
-5% -$1.65M 0.28% 90
2021
Q3
$33.4M Sell
478,010
-8,147
-2% -$572K 0.29% 86
2021
Q2
$33.5M Buy
486,157
+67,578
+16% +$4.51M 0.27% 92
2021
Q1
$27.1M Buy
418,579
+9,711
+2% +$626K 0.23% 110
2020
Q4
$23.8M Sell
408,868
-29,662
-7% -$1.79M 0.22% 112
2020
Q3
$27.7M Sell
438,530
-3,100
-0.7% -$215K 0.28% 94
2020
Q2
$34M Buy
441,630
+26,953
+6% +$2.07M 0.36% 74
2020
Q1
$31M Sell
414,677
-37,816
-8% -$2.61M 0.37% 72
2019
Q4
$29.4M Buy
452,493
+45,168
+11% +$2.94M 0.32% 82
2019
Q3
$25.8M Buy
407,325
+2,928
+0.7% +$191K 0.29% 88
2019
Q2
$27.3M Buy
404,397
+62,980
+18% +$4.14M 0.3% 86
2019
Q1
$22.2M Buy
341,417
+67,924
+25% +$4.51M 0.24% 90
2018
Q4
$17.1M Buy
273,493
+24,830
+10% +$1.74M 0.21% 97
2018
Q3
$19.2M Buy
248,663
+15,062
+6% +$1.14M 0.19% 98
2018
Q2
$16.5M Buy
233,601
+20,659
+10% +$1.46M 0.16% 100
2018
Q1
$16.1M Buy
212,942
+39,383
+23% +$3.13M 0.16% 102
2017
Q4
$12.4M Buy
+173,559
New +$13.2M 0.11% 108

Other funds holding GILD